Active surveillance (AS) has been introduced as an observational strategy to delay or avoid curative treatment without compromising long-term cancer-specific survival.
The 10 studies included in this review, published between 2008 and 2013, generally agreed upon patients selection for the AS strategy and how they should be managed within the program. However, uncertainties persists concerning optimal patient selection and reliable progression criteria, as well as the long-term safety of AS.
Written by:
Thomsen FB, Brasso K, Klotz LH, Røder MA, Berg KD, Iversen P. Are you the author?
Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Denmark.
Reference: J Surg Oncol. 2014 Mar 7. Epub ahead of print.
doi: 10.1002/jso.23584
PubMed Abstract
PMID: 24610744
UroToday.com Prostate Cancer Section
